Abstract
Non-invasive vascular ultrasound has been introduced in patient specific cardio/cerebro-vascular risk evaluation, treatment efficiency estimation, and drug-development strategies. The ultrasound measurement system is based on analysis of radio frequency echo data and is usually combined with evaluations of textural, contextual, morphological and clinical features in a multi-parameter approach. Processing of radio frequency data enables individual vascular risk evaluation depending on the clinical purpose. The non-invasive nature of radio frequency based techniques makes them suitable for screening large populations, and evaluation of drug efficiency in vascular risk reduction.
Keywords
Get full access to this article
View all access options for this article.
